Escavite D (GM Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Escavite D drug offered from GM Pharmaceuticals, Inc.. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Antidote [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GM Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, HYDROXOCOBALAMIN, BIOTIN, CALCIUM PANTOTHENA |
SUBSTANCE NAME: | .BETA.-CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL, DL-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; HYDROXOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Antidote [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2014-03-03 |
END MARKETING DATE: | 0000-00-00 |
Escavite D HUMAN PRESCRIPTION DRUG Details:
Item Description | Escavite D from GM Pharmaceuticals, Inc. |
LABELER NAME: | GM Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2500; 100; 600; 30; 1.5; 1.7; 20; 2; 400; 6; 45; 10; 6; 60; 15; 2; .25([iU]/1; mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2014-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58809-829_294e41a8-6432-4edf-abf4-35b2a96eec1e |
PRODUCT NDC: | 58809-829 |
APPLICATION NUMBER: | |
Other .BETA.-CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL, DL-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; HYDROXOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENA Pharmaceutical Manufacturers / Labelers: